These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3387440)

  • 1. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.
    Senter PD; Saulnier MG; Schreiber GJ; Hirschberg DL; Brown JP; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4842-6. PubMed ID: 3387440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates.
    Senter PD; Schreiber GJ; Hirschberg DL; Ashe SA; Hellström KE; Hellström I
    Cancer Res; 1989 Nov; 49(21):5789-92. PubMed ID: 2790791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate.
    Haisma HJ; Boven E; van Muijen M; De Vries R; Pinedo HM
    Cancer Immunol Immunother; 1992; 34(5):343-8. PubMed ID: 1540981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells.
    Kim KY; Cho YJ; Jeon GA; Ryu PD; Myeong JN
    Mol Cell Biochem; 2003 Oct; 252(1-2):213-21. PubMed ID: 14577595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate.
    Wallace PM; Senter PD
    Bioconjug Chem; 1991; 2(5):349-52. PubMed ID: 1790175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.
    Svensson HP; Vrudhula VM; Emswiler JE; MacMaster JF; Cosand WL; Senter PD; Wallace PM
    Cancer Res; 1995 Jun; 55(11):2357-65. PubMed ID: 7757987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
    Svensson HP; Frank IS; Berry KK; Senter PD
    J Med Chem; 1998 Apr; 41(9):1507-12. PubMed ID: 9554883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.
    Sahin U; Hartmann F; Senter P; Pohl C; Engert A; Diehl V; Pfreundschuh M
    Cancer Res; 1990 Nov; 50(21):6944-8. PubMed ID: 2170012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy.
    Senter PD
    FASEB J; 1990 Feb; 4(2):188-93. PubMed ID: 2404820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaline phosphatase-triggered assembly of etoposide enhances its anticancer effect.
    Kiran S; Hai Z; Ding Z; Wang L; Liu Y; Zhang H; Liang G
    Chem Commun (Camb); 2018 Feb; 54(15):1853-1856. PubMed ID: 29387836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
    Shabat D; Lode HN; Pertl U; Reisfeld RA; Rader C; Lerner RA; Barbas CF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7528-33. PubMed ID: 11404472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.
    Meyer DL; Jungheim LN; Law KL; Mikolajczyk SD; Shepherd TA; Mackensen DG; Briggs SL; Starling JJ
    Cancer Res; 1993 Sep; 53(17):3956-63. PubMed ID: 8358723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
    Deckert PM; Bornmann WG; Ritter G; Williams C; Franke J; Keilholz U; Thiel E; Old LJ; Bertino JR; Welt S
    Int J Oncol; 2004 May; 24(5):1289-95. PubMed ID: 15067353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of antibody enzyme conjugates in combination with prodrugs.
    Senter PD
    Front Radiat Ther Oncol; 1990; 24():132-41; discussion 161-5. PubMed ID: 2341048
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates.
    Smyth MJ; Foster HM; Andrew SM; Teh JG; Krauer K; McKenzie IF; Pietersz GA
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():167-79. PubMed ID: 8349300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
    Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
    Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
    Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-selective prodrug activation by fusion protein-mediated catalysis.
    Bosslet K; Czech J; Hoffmann D
    Cancer Res; 1994 Apr; 54(8):2151-9. PubMed ID: 8174122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
    Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
    Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.
    Vrudhula VM; Svensson HP; Kennedy KA; Senter PD; Wallace PM
    Bioconjug Chem; 1993; 4(5):334-40. PubMed ID: 8274516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.